Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Clinics ; 68(9): 1255-1262, set. 2013. graf
Article in English | LILACS | ID: lil-687753

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate the effect of a novel phytoestrogen, α-Zearalanol, on Alzheimer's disease-related memory impairment and neuronal oxidation in ovariectomized mice. METHODS: Female C57/BL6 mice were ovariectomized or received sham operations and treatment with equivalent doses of 17β-estradiol or α-Zearalanol for 8 weeks. Their spatial learning and memory were analyzed using the Morris water maze test. The antioxidant enzyme activities and reactive oxygen species generation, neuronal DNA oxidation, and MutT homolog 1 expression in the hippocampus were measured. RESULTS: Treatment with 17β-estradiol or α-Zearalanol significantly improved spatial learning and memory performance in ovariectomized mice. In addition, 17β-estradiol and α-Zearalanol attenuated the decrease in antioxidant enzyme activities and increased reactive oxygen species production in ovariectomized mice. The findings indicated a significant elevation in hippocampi neuronal DNA oxidation and reduction in MutT homolog 1 expression in estrogen-deficient mice, but supplementation with 17β-estradiol or α-Zearalanol efficaciously ameliorated this situation. CONCLUSION: These results demonstrate that α-Zearalanol is potentially beneficial for improving memory impairments and neuronal oxidation damage in a manner similar to that of 17β-estradiol. Therefore, the compound may be a potential therapeutic agent that can ameliorate neurodegenerative disorders related to estrogen deficiency. .


Subject(s)
Animals , Female , Mice , Alzheimer Disease/drug therapy , Estradiol/therapeutic use , Memory Disorders/drug therapy , Ovariectomy , Oxidative Stress/drug effects , Phytoestrogens/therapeutic use , Zeranol/analogs & derivatives , Blotting, Western , DNA Damage/drug effects , DNA Repair Enzymes/analysis , Hippocampus/drug effects , Immunohistochemistry , Phosphoric Monoester Hydrolases/analysis , Reproducibility of Results , Time Factors , Treatment Outcome , Zeranol/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL